Ardelyx, Inc.
NasdaqGM:ARDX
Sector
Industries
Location
Market Cap
USD 1.44 B
Share Price
USD 5.97
Avg Daily Volume
4,631,206
Change (1 day)
2.23%
Change (1 year)
1.53%
Change (YTD)
17.75%
Ardelyx, Inc. Key Metrics 2015 - 2025
This table shows the Key Metrics for Ardelyx, Inc. going from 2015 until 2025. Key metrics are specific quantitative measures used to assess the performance and progress of a company, often tailored to its industry and objectives, providing insights into growth, profitability, and operational efficiency.
Key Metrics
| Annual data in millions of USD, except per share data | Trend |
|---|
Competitors
Eli Lilly and Company
USD 701.23
LLY
+16.80
2.46%
AbbVie Inc.
USD 206.69
ABBV
+2.01
0.98%
Roche Holding AG
USD 331.61
RO.SW
+7.43
2.29%
Novartis AG
USD 123.29
NOVN.SW
+1.51
1.24%
AstraZeneca PLC
USD 150.15
AZN.L
-2.01
-1.32%
Novo Nordisk A/S
USD 50.97
NOVO-B.CO
+0.44
0.87%
Merck & Co., Inc.
USD 84.21
MRK
+1.45
1.75%
Thermo Fisher Scientific Inc.
USD 489.01
TMO
+3.97
0.82%
Amgen Inc.
USD 296.47
AMGN
+6.18
2.13%
Gilead Sciences, Inc.
USD 118.37
GILD
-0.65
-0.55%
Pfizer Inc.
USD 25.14
PFE
+0.03
0.12%
Sanofi
USD 99.43
SAN.PA
+2.12
2.18%
Vertex Pharmaceuticals Incorporated
USD 392.79
VRTX
+2.49
0.64%
Bristol-Myers Squibb Company
USD 48.44
BMY
+0.63
1.32%
Chugai Pharmaceutical Co., Ltd.
USD 42.42
4519.T
+0.95
2.29%